Status:
RECRUITING
Influenza Immunization in Adults Over Age 75
Lead Sponsor:
Johns Hopkins University
Conditions:
Influenza
Immunization
Eligibility:
All Genders
75+ years
Phase:
NA
Brief Summary
The immune system is the part of the body that protects against infection. The immune system often doesn't work as effectively as people get older. This research is being done to find out how the immu...
Detailed Description
Seasonal influenza causes significant morbidity and mortality and is the fourth leading cause of death for older Americans. Annual immunization with a trivalent inactivated influenza vaccine (TIV) is ...
Eligibility Criteria
Inclusion
- Adults over age 75 years
Exclusion
- Allergies to egg or vaccine
- Active malignancies
- On radiation or chemotherapy
- Active systemic inflammatory diseases including rheumatoid arthritis, Crohn's disease, and ulcerative colitis
- Acute exacerbation of chronic cardiopulmonary conditions including decompensated CHF or COPD
- Taking oral steroids (such as prednisone) or immune modulating drugs (such as methotrexate).
- Lacking the capacity to consent (individuals who do not understand what Flu shot is or need someone else to decide if s/he should get the Flu shot)
Key Trial Info
Start Date :
March 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2027
Estimated Enrollment :
1025 Patients enrolled
Trial Details
Trial ID
NCT02200276
Start Date
March 1 2014
End Date
November 30 2027
Last Update
March 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University; JHAAC 5501 Hopkins Bayview Circle, 1B84
Baltimore, Maryland, United States, 21224